Open access
Open access
Powered by Google Translator Translator

Otolaryngology/Head and Neck (all articles)

Review: Tympanostomy tubes for children with acute otitis media.

23 May, 2022 | 00:46h | UTC

Tympanostomy tubes for children with acute otitis media – Canadian Family Physician

 


M-A: Complication rates of total thyroidectomy vs. hemithyroidectomy for treatment of papillary thyroid microcarcinoma.

11 May, 2022 | 10:59h | UTC

Complication Rates of Total Thyroidectomy vs Hemithyroidectomy for Treatment of Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – $ for full-text)

 

Commentary on Twitter

 


ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer.

5 May, 2022 | 10:16h | UTC

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer – Annals of Oncology

 


10-year results of a RCT: Effects of parathyroidectomy vs. observation on morbidity and mortality in patients with mild primary hyperparathyroidism.

1 May, 2022 | 23:22h | UTC

Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentary: Parathyroidectomy No Better for Mild Primary Hyperparathyroidism – HealthDay

 

Commentary on Twitter

 


Why does the Omicron variant largely spare olfactory function? implications for the pathogenesis of anosmia in COVID-19.

26 Apr, 2022 | 08:05h | UTC

Why does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in COVID-19 – The Journal of Infectious Diseases

 


RCT: Sintilimab vs. placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic esophageal squamous cell carcinoma.

20 Apr, 2022 | 09:28h | UTC

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial – The BMJ

 

Commentary on Twitter

 


Development and validation of machine learning models for predicting occult nodal metastasis in early-stage oral cavity squamous cell carcinoma.

20 Apr, 2022 | 09:14h | UTC

Development and Validation of Machine Learning Models for Predicting Occult Nodal Metastasis in Early-Stage Oral Cavity Squamous Cell Carcinoma – JAMA Network Open

 

Commentary on Twitter

 


M-A of randomized trials: Intraoperative recurrent laryngeal nerve monitoring vs. visualization alone.

19 Apr, 2022 | 01:17h | UTC

Intraoperative recurrent laryngeal nerve monitoring versus visualisation alone – A systematic review and meta-analysis of randomized controlled trials – American Journal of Surgery

 


A randomized controlled trial explored the safety and tolerability of Sulthiame in sleep apnea.

18 Apr, 2022 | 10:08h | UTC

A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea – American Journal of Respiratory and Critical Care Medicine

News Release: Drug reduced frequency of breathing pauses in sleep apnea – University of Gothenburg

 

Commentary on Twitter

 


Cross-sectional study: evaluating prediction models of sleep apnea from smartphone-recorded sleep breathing sounds.

18 Apr, 2022 | 09:44h | UTC

Evaluating Prediction Models of Sleep Apnea From Smartphone-Recorded Sleep Breathing Sounds – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – for full-text)

 

Commentary on Twitter

 


Development and validation of a decision analytical model for posttreatment surveillance for patients with oropharyngeal carcinoma.

14 Apr, 2022 | 07:52h | UTC

Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal Carcinoma – JAMA Network Open

 


M-A: The clinical effect and safety of new preoperative fasting time guidelines for elective surgery.

12 Apr, 2022 | 09:51h | UTC

The clinical effect and safety of new preoperative fasting time guidelines for elective surgery: a systematic review and meta-analysis – Gland Surgery

Related:

An international multidisciplinary consensus statement on fasting before procedural sedation in adults and children – Anaesthesia

Does my hospitalized patient need an NPO-after-midnight order preoperatively?

ESPEN practical guideline: Clinical nutrition in surgery – “Preoperative fasting from midnight is unnecessary in most patients. Patients undergoing surgery, who are considered to have no specific risk of aspiration, shall drink clear fluids until 2 h before anesthesia. Solids shall be allowed until 6 h before anesthesia.”

Pro-Con Debate: 1- vs 2-Hour Fast for Clear Liquids Before Anesthesia in Children.

Editorial: The rationale for the recommendations of the European Pediatric Fasting Guideline – “the authors of the 2021 ESAIC pediatric guideline have found reasons to recommend reductions to the minimum fasting times for infant formula to 4 h, for breast milk to 3 h and for clear fluids to 1 h”.

Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration

Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology

Clear fluids fasting for elective paediatric anaesthesia: The European Society of Anaesthesiology consensus statement – European Journal of Anaesthesiology

Canadian Pediatric Anesthesia Society statement on clear fluid fasting for elective pediatric anesthesia – Canadian Journal of Anesthesia (free)

 


M-A: Association of olfactory impairment with all-cause mortality.

11 Apr, 2022 | 01:01h | UTC

Association of Olfactory Impairment With All-Cause Mortality: A Systematic Review and Meta-analysis – JAMA Otolaryngology-Head & Neck Surgery (free for a limited period)

Invited Commentary: Olfactory Impairment and Mortality—Is Smell Loss Deadly? – JAMA Otolaryngology-Head & Neck Surgery (free for a limited period)

 

Commentary on Twitter

 


M-A: Advanced computed tomographic localization techniques for primary hyperparathyroidism.

6 Apr, 2022 | 09:57h | UTC

Advanced Computed Tomographic Localization Techniques for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – $ for full-text)

 


Podcast: Deep dive into deep neck infections in children.

31 Mar, 2022 | 07:57h | UTC

#47: Deep Dive into Deep Neck Infections with Dr. Travis Crook – The Cribsiders

 


SEOM-TTCC clinical guideline in nasopharynx cancer.

25 Mar, 2022 | 08:20h | UTC

SEOM-TTCC clinical guideline in nasopharynx cancer (2021) – Clinical and Translational Oncology

 


Consensus Statement | Minimally-invasive treatments for benign thyroid nodules: recommendations for information to patients and referring physicians.

24 Mar, 2022 | 08:42h | UTC

Minimally-invasive treatments for benign thyroid nodules: recommendations for information to patients and referring physicians by the Italian Minimally-Invasive Treatments of the Thyroid group – Endocrine

 


Position Paper | Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy.

24 Mar, 2022 | 08:34h | UTC

Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy – A German position paper from Surgery and Nuclear Medicine – Nuclear Medicine

Related: RCT: In patients with low-risk thyroid cancer, thyroidectomy without ablation radioiodine was noninferior to thyroidectomy with ablation radioiodine at 3 years.

 


Review: When to operate after SARS-CoV-2 infection?

22 Mar, 2022 | 09:44h | UTC

When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA – Langenbeck’s Archives of Surgery

Related:

Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

 


RCT: Elective upper-neck vs. whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma.

9 Mar, 2022 | 08:17h | UTC

Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentaries:

Elective Upper-Neck vs Whole-Neck Irradiation in Nasopharyngeal Carcinoma – The ASCO Post

Lower Neck-Sparing RT Succeeds in Nasopharyngeal Carcinoma— Phase III trial also shows that upper-neck irradiation leads to fewer late toxicities – MedPage Today (link to abstract – $ for full-text)

 


WHO global standard for safe listening venues and events.

7 Mar, 2022 | 00:17h | UTC

WHO global standard for safe listening venues and events – World Health Organization

Q&A: Deafness and hearing loss: Safe listening – World Health Organization

Commentaries:

WHO Releases New Noise Standard for Public Venues to Tackle Hearing Loss – Health Polity Watch

Obesity rates likely to double by 2030 with highest rises in lower-income countries – The Guardian

 

Commentary on Twitter (thread – click for more)

 


RCT: In operated patients with head and neck cancer, chemoradiotherapy with weekly cisplatin is noninferior to 3-weekly cisplatin and is associated with reduced toxicity.

3 Mar, 2022 | 08:11h | UTC

Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial – Journal of Clinical Oncology

 

Commentary from the author on Twitter

 


Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.

1 Mar, 2022 | 08:58h | UTC

Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia

Related:

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

 


HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.

1 Mar, 2022 | 08:30h | UTC

HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management – Nature Reviews Clinical Oncology (if the link is paywalled, try this one)

 


RCT: Time to functional recovery after laser tonsillotomy performed under local anesthesia vs. conventional tonsillectomy with general anesthesia among adults.

22 Feb, 2022 | 08:22h | UTC

Time to Functional Recovery After Laser Tonsillotomy Performed Under Local Anesthesia vs Conventional Tonsillectomy With General Anesthesia Among Adults: A Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.